Determining the clinical significance of pathological findings in prostate cancer

被引：1
|
作者：
Takahashi, Takeshi [1 ]
机构：
[1] Hlth & Welf Bur, Kitakyushu City Off, Jyonai 1-1, Kitakyushu 8038501, Japan
来源：
VIRCHOWS ARCHIV | 2024年
关键词：
HISTORY;
D O I：
10.1007/s00428-024-03804-w
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Transrectal electrical impedance tomography of the prostate: Spatially coregistered pathological findings for prostate cancer detection
    Wan, Yuqing
    Borsic, Andrea
    Heaney, John
    Seigne, John
    Schned, Alan
    Baker, Michael
    Wason, Shaun
    Hartov, Alex
    Halter, Ryan
    MEDICAL PHYSICS, 2013, 40 (06)
  • [32] IGFBP2 in cancer: Pathological role and clinical significance
    Wei, Lai-Feng
    Weng, Xue-Fen
    Huang, Xu-Chun
    Peng, Yu-Hui
    Guo, Hai-Peng
    Xu, Yi-Wei
    ONCOLOGY REPORTS, 2021, 45 (02) : 427 - 438
  • [33] RESPONSE OF BREAST CANCER TO TRIETHYLENE THIOPHOSPHORAMIDE - PATHOLOGICAL AND CLINICAL FINDINGS
    MOORE, GE
    PICKREN, JW
    ARCHIVES OF PATHOLOGY, 1958, 65 (01): : 98 - 103
  • [34] Clinical significance of TMPRSS4 in prostate cancer
    Shi, Guohai
    Yang, Xiaoqun
    Dai, Bo
    Zhang, Hailiang
    Shen, Yijun
    Zhu, Yao
    Zhu, Yiping
    Xiao, Wenjun
    Ma, Chunguang
    Wen, Linguo
    Qin, Xiaojian
    Cao, Dalong
    Ye, Dingwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (11): : 8053 - 8058
  • [35] Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
    Chen, Tzu-Yi
    Mihalopoulos, Meredith
    Zuluaga, Laura
    Rich, Jordan
    Ganta, Teja
    Mehrazin, Reza
    Tsao, Che-Kai
    Tewari, Ash
    Gonzalez-Kozlova, Edgar
    Badani, Ketan
    Dogra, Navneet
    Kyprianou, Natasha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [36] CLINICAL SIGNIFICANCE OF BRAF AND KRAS MUTATIONS IN PROSTATE CANCER
    Choi, S.
    Chung, J. M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 240 - 240
  • [37] PREVALENCE AND CLINICAL SIGNIFICANCE OF CHROMOSOMAL DELETIONS IN PROSTATE CANCER
    Minner, S.
    Burkhardt, L.
    Krohn, A.
    Tennstedt, P.
    Simon, R.
    Salomon, G.
    Steuber, T.
    Heinzer, H.
    Sauter, G.
    Schlomm, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 172 - 172
  • [38] The clinical significance of circulating tissue factor in prostate cancer
    Nieva, Jorge
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (03) : 329 - 330
  • [39] Clinical and pathological interrelationships between nodular hyperplasia and prostate cancer
    Ewton, AA
    Kattan, MW
    Shimura, S
    Suyama, K
    Slawin, KM
    Scardino, PT
    Wheeler, TM
    MODERN PATHOLOGY, 1998, 11 (01) : 82A - 82A
  • [40] Angiogenesis and prostate cancer: Important laboratory and clinical findings
    Cox M.C.
    Permenter M.
    Figg W.D.
    Current Oncology Reports, 2005, 7 (3) : 215 - 219
12345